Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Disc Medicine, Inc.

IRONNASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Aug 6, 2026Accepted Aug 6, 2026, 4:27 PM EDTFiling CIK 1816736Accession 0001950047-26-007754
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
DISC MEDICINE INC.
Issuer CIK
0001816736
SEC file number
001-39438
Phone
6176749274
Person for whose account securities are to be sold
RAHUL KHARA
Relationships to issuer
Officer
Street
321 Arsenal Street, Suite 101
City
Watertown
State / country code
MA
Postal code
02472

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common5,000394,550.0038,392,84408/06/2026NASDAQMorgan Stanley Smith Barney LLC Executive Financial Services

Broker / market maker — proposed row 1, entry 1

Name
Morgan Stanley Smith Barney LLC Executive Financial Services
Street
1 New York Plaza
Street (continued)
8th Floor
City
New York
State / country code
NY
Postal code
10004

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common08/06/2026Exercise of Stock OptionsIssuer5,000N08/06/2026Cash

Sales reported in the preceding three months

Sales reported in the preceding three months · 3 reported rows
SellerSecuritySale dateAmount soldGross proceeds
10b5-1 Sales for RAHUL KHARACommon06/29/20261,649123,675.00
10b5-1 Sales for RAHUL KHARACommon06/26/202685163,825.00
10b5-1 Sales for RAHUL KHARACommon06/18/20267,500526,660.50

Seller — prior-sale row 1, entry 1

Name
10b5-1 Sales for RAHUL KHARA
Street
321 Arsenal Street, Suite 101
City
Watertown
State / country code
MA
Postal code
02472

Seller — prior-sale row 2, entry 1

Name
10b5-1 Sales for RAHUL KHARA
Street
321 Arsenal Street, Suite 101
City
Watertown
State / country code
MA
Postal code
02472

Seller — prior-sale row 3, entry 1

Name
10b5-1 Sales for RAHUL KHARA
Street
321 Arsenal Street, Suite 101
City
Watertown
State / country code
MA
Postal code
02472

Prior-sale reporting

Nothing to report for the preceding three months
N

Notice signature

Notice date
08/06/2026
Signed
/s/ Rahul Khara
Plan adoption dates
03/19/2026

Company context

Disc Medicine (NASDAQ: IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis.

Current securities

Historical securities (1)

Recent company filings

  1. Entry into a Material Definitive Agreement · Results of Operations and Financial Condition · Other EventsOct 22, 2026
  2. 4 filingOct 21, 2026
  3. 424B5 filingOct 21, 2026
  4. 144 filingOct 21, 2026
  5. 144 filingOct 21, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.